Rs2237895

nature type-2 diabetes
 * rs2237895, P = 7.3 times 10-9; OR = 1.32, 95% CI = 1.20&#226;&#8364;&#8220;1.45

SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations.

Meta-analysis in genome-wide association studies.

Genetic variation in KCNQ1 associates with fasting glucose and beta-cell function: a study of 3,734 subjects comprising three ethnicities living in Singapore.

Common variants in KCNQ1 are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population.

Polymorphisms in KCNQ1 are associated with gestational diabetes in a Korean population.

KCNQ1 gene polymorphisms are associated with lipid parameters in a Chinese Han population.

Variants in KCNQ1 increase type II diabetes susceptibility in South Asians: a study of 3,310 subjects from India and the US.

Genetic risk profiling for prediction of type 2 diabetes.

Effects of KCNQ1 polymorphisms on the therapeutic efficacy of oral antidiabetic drugs in Chinese patients with type 2 diabetes.

Evidence for somatic gene conversion and deletion in bipolar disorder, Crohn's disease, coronary artery disease, hypertension, rheumatoid arthritis, type-1 diabetes, and type-2 diabetes.

KCNQ1 gene variants and risk of new-onset diabetes in tacrolimus-treated renal-transplanted patients.

KCNQ1 gene polymorphisms are associated with the therapeutic efficacy of repaglinide in Chinese Type 2 diabetic patients.

Diabetes-associated common genetic variation and its association with GLP-1 concentrations and response to exogenous GLP-1.